welcome
TechCrunch

TechCrunch

Health

Health

Early cancer detection startup Craif raises $22M | TechCrunch

TechCrunch
Summary
Nutrition label

85% Informative

Craif has raised $22 million in Series C funding to expand into the U.S. market and bolster its R&D.

The Japanese startup is using microRNA(miRNA) to develop an AI-powered early cancer detection software.

Craif's first product, miSignal, a test that detects the risk of seven different cancers, is already generating revenues in Japan .